<DOC>
	<DOCNO>NCT00006456</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery delivers x-ray directly tumor may cause less damage normal tissue . PURPOSE : Phase II trial study effectiveness stereotactic radiosurgery treat patient liver metastasis , lung metastasis , advance solid tumor .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Treating Patients With Liver Metastases , Lung Metastases , Other Advanced Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility fractionate stereotactic body radiosurgery patient advance extracranial tumor . - Assess toxicity treatment regimen patient . - Determine tumor response cause death patient treat regimen . OUTLINE : Patients receive fractionate stereotactic body radiosurgery 30 minute 5-10 day total 3 treatment . Patients follow every 3 month . PROJECTED ACCRUAL : A total 10-25 patient accrue within 2-3 year .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm malignancy Extracranial recurrent metastatic disease primary tumor predict controlled standard radiotherapy Incurable standard therapy No tumor involve critical structure ( e.g. , mucosal surface ( bowel bladder ) heart ) Tumor visible CT scan PATIENT CHARACTERISTICS : Age : Not specify Performance status : Karnofsky 60100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Bilirubin le 2.0 time upper limit normal ( ULN ) AST ALT less 5 time ULN Renal : Creatinine le 2.0 mg/dL Pulmonary : FEV1 great 0.75 L Other : No unsuitable size geometric proportion would preclude stereotactic immobilization Not pregnant nursing Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : At least 14 day since prior anticancer biologic therapy recover Chemotherapy : At least 14 day since prior anticancer chemotherapy recover Endocrine therapy : At least 14 day since prior anticancer endocrine therapy recover Radiotherapy : See Disease Characteristics At least 14 day since prior anticancer radiotherapy recover Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>lung metastasis</keyword>
	<keyword>liver metastasis</keyword>
</DOC>